TGFB1 and neoplasm: In preclinical models, DNtransduced EBV-specific T cells have a functional advantage over unmodified T cells: they were resistant to TGFβ-mediated inhibition of proliferation cytolytic activity and mediated superior antitumor activity in a murine tumor model.